Jiangsu Lianhuan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Jiangsu Lianhuan Pharmaceutical has a total shareholder equity of CN¥1.6B and total debt of CN¥721.3M, which brings its debt-to-equity ratio to 46.4%. Its total assets and total liabilities are CN¥2.8B and CN¥1.3B respectively. Jiangsu Lianhuan Pharmaceutical's EBIT is CN¥185.7M making its interest coverage ratio 7.3. It has cash and short-term investments of CN¥237.1M.
Key information
46.4%
Debt to equity ratio
CN¥721.31m
Debt
Interest coverage ratio | 7.3x |
Cash | CN¥237.13m |
Equity | CN¥1.55b |
Total liabilities | CN¥1.28b |
Total assets | CN¥2.83b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600513's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 600513's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥91.7M).
Debt to Equity History and Analysis
Debt Level: 600513's net debt to equity ratio (31.2%) is considered satisfactory.
Reducing Debt: 600513's debt to equity ratio has increased from 15.2% to 46.4% over the past 5 years.
Debt Coverage: 600513's debt is well covered by operating cash flow (22%).
Interest Coverage: 600513's interest payments on its debt are well covered by EBIT (7.3x coverage).